USA - NASDAQ:AVAH - US05356F1057 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to AVAH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-10-28 | Jefferies | Maintains | Buy -> Buy | 
| 2025-10-24 | RBC Capital | Maintains | Sector Perform -> Sector Perform | 
| 2025-10-13 | UBS | Maintains | Neutral -> Neutral | 
| 2025-09-18 | JP Morgan | Upgrade | Underweight -> Neutral | 
| 2025-08-19 | UBS | Upgrade | Sell -> Neutral | 
| 2025-08-19 | Barclays | Upgrade | Equal-Weight -> Overweight | 
| 2025-08-12 | UBS | Maintains | Sell -> Sell | 
| 2025-08-11 | Raymond James | Upgrade | Market Perform -> Outperform | 
| 2025-07-21 | Jefferies | Upgrade | Hold -> Buy | 
| 2025-07-16 | Truist Securities | Maintains | Hold -> Hold | 
| 2025-07-02 | Barclays | Initiate | Equal-Weight | 
| 2025-05-09 | UBS | Maintains | Sell -> Sell | 
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold | 
| 2025-03-14 | UBS | Maintains | Sell -> Sell | 
| 2025-01-06 | Truist Securities | Maintains | Hold -> Hold | 
| 2024-08-09 | UBS | Maintains | Sell -> Sell | 
| 2024-08-09 | Deutsche Bank | Maintains | Buy -> Buy | 
| 2024-08-09 | RBC Capital | Maintains | Sector Perform -> Sector Perform | 
| 2024-03-18 | Deutsche Bank | Maintains | Buy -> Buy | 
| 2023-12-13 | JP Morgan | Downgrade | Neutral -> Underweight | 
| 2023-08-11 | Credit Suisse | Reiterate | Underperform -> Underperform | 
| 2023-07-13 | Truist Securities | Maintains | Hold -> Hold | 
| 2023-05-15 | RBC Capital | Reiterate | Sector Perform -> Sector Perform | 
| 2023-05-12 | Raymond James | Downgrade | Strong Buy -> Market Perform | 
| 2023-05-12 | Credit Suisse | Reiterate | Underperform -> Underperform | 
| 2023-03-20 | RBC Capital | Maintains | Sector Perform | 
| 2023-03-20 | Raymond James | Maintains | Strong Buy | 
| 2023-03-17 | Truist Securities | Maintains | Hold | 
| 2023-01-27 | Credit Suisse | Downgrade | Neutral -> Underperform | 
| 2022-11-21 | RBC Capital | Downgrade | Outperform -> Sector Perform | 
15 analysts have analysed AVAH and the average price target is 8.83 USD. This implies a price decrease of -5.47% is expected in the next year compared to the current price of 9.34.
The consensus rating for AVEANNA HEALTHCARE HOLDINGS (AVAH) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.